カテゴリ： MarketLine, エストニア, 企業調査

Eesti Energia AS：企業の戦略・SWOT・財務分析

◆英語タイトル：Eesti Energia AS - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3852
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：40
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：エストニア
◆産業分野：Oil and Gas
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Eesti Energia AS – Strategy, SWOT and Corporate Finance Report
Summary

Eesti Energia AS – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Eesti Energia AS (Eesti Energia or ‘the company’) is an energy company that operates in the gas and electricity markets. It offers energy solutions including heat, electricity, and fuel production to customer service and sales, and many other energy services. Further, the company produces produces electricity from wind, water, biogas, sunlight, biomass and municipal waste. The company caters its product and services to wide range of industries including heat producers, energy businesses, chemical industry businesses, road builders, agricultural producers and various production businesses. Through subsidiaries, Eesti Energia operates in Estonia, Latvia, Lithuania, Switzerland, Poland, Singapore, and Nordic countries. The company is headquartered in Tallinn, Estonia.

Scope

- Detailed information on Eesti Energia AS required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eesti Energia AS in the form of a SWOT analysis
- An in-depth view of the business model of Eesti Energia AS including a breakdown and examination of key business segments
- Intelligence on Eesti Energia AS’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eesti Energia AS, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Eesti Energia AS and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eesti Energia AS as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Eesti Energia AS’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Eesti Energia AS: Company Overview
Eesti Energia AS: Overview and Key Facts
Eesti Energia AS: Overview
Eesti Energia AS: Key Facts
Eesti Energia AS: Key Employees
Eesti Energia AS: Key Employee Biographies
Eesti Energia AS: Major Products and Services
Eesti Energia AS: Company History
Eesti Energia AS: Management Statement
Eesti Energia AS: Locations and Subsidiaries
Eesti Energia AS: Key Competitors
Eesti Energia AS: Company Analysis
Eesti Energia AS: Business Description
Eesti Energia AS: SWOT Analysis
Eesti Energia AS: SWOT Overview
Eesti Energia AS: Strengths
Eesti Energia AS: Weaknesses
Eesti Energia AS: Opportunities
Eesti Energia AS: Threats
Eesti Energia AS: Recent Developments
Eesti Energia AS: News and Events Summary
Eesti Energia AS: Business Expansion
Eesti Energia AS: Contracts
Eesti Energia AS: Corporate Governance
Eesti Energia AS: Financial Deals
Eesti Energia AS: Financial Performance
Eesti Energia AS: Regulatory and Legal Events
Eesti Energia AS: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Eesti Energia AS: Key Facts
Table 2: Eesti Energia AS: Key Employees
Table 3: Eesti Energia AS: Company History
Table 4: Eesti Energia AS: Locations and Subsidiaries
Table 5: Eesti Energia AS: Key Competitors
Table 6: Eesti Energia AS: News and Events Summary
Table 7: Eesti Energia AS: Business Expansion
Table 8: Eesti Energia AS: Contracts
Table 9: Eesti Energia AS: Corporate Governance
Table 10: Eesti Energia AS: Financial Deals
Table 11: Eesti Energia AS: Financial Performance
Table 12: Eesti Energia AS: Regulatory and Legal Events
Table 13: Eesti Energia AS: Strategy and Operations

★海外企業調査レポート[Eesti Energia AS：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • BerGenBio ASA (BGBIO)-製薬・医療分野：企業M&A・提携分析
    Summary BerGenBio ASA (BerGenBio) is a developer of drugs for aggressive and drug resistant cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 finds application in the treatment of drug resistant chronic myeloid l …
  • Pt Pioneerindo Gourmet International Tbk：企業の戦略・SWOT・財務分析
    Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • NextEra Energy Resources LLC-エネルギー分野：企業M&A・提携分析
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • Aerospace Industrial Development Corporation：企業の戦略・SWOT・財務情報
    Aerospace Industrial Development Corporation - Strategy, SWOT and Corporate Finance Report Summary Aerospace Industrial Development Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Emory Healthcare Corporate：製薬・医療：M&Aディール及び事業提携情報
    Summary Emory Healthcare Corporate (Emory Healthcare) is a healthcare service provider. The center offers treatments such as acl injuries, aging, als and related conditions, bleeding disorders, bone and tissue tumors, brain health, cancer conditions, dental implants, dermatology, digestive diseases; …
  • Neurovance Inc-製薬・医療分野：企業M&A・提携分析
    Summary Neurovance Inc (Neurovance) is a clinical stage neuroscience focused company that develops centanafadine (CTN) SR for adult and pediatric Attention Deficit Hyperactivity Disorder (ADHD). CTN, formerly EB-1020, is a novel triple reuptake inhibitor that acts as a functional hybrid with activit …
  • Pascal Biosciences Inc (PAS)-製薬・医療分野：企業M&A・提携分析
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve …
  • Matinas BioPharma Holdings Inc (MTNB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …
  • Astaldi Spa
    Astaldi Spa - Strategy, SWOT and Corporate Finance Report Summary Astaldi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • LGT Group Foundation：企業の戦略・SWOT・財務情報
    LGT Group Foundation - Strategy, SWOT and Corporate Finance Report Summary LGT Group Foundation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Horizon Discovery Group Plc (HZD)：企業の財務・戦略的SWOT分析
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • Molson Coors Brewing Co (TAP)：企業の財務・戦略的SWOT分析
    Molson Coors Brewing Co (TAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Itamar Medical Ltd (ITMR)：企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. It develops products using its proprietary peripheral arterial tonometry (PAT) …
  • Lamprell Plc (LAM)：企業の財務・戦略的SWOT分析
    Lamprell Plc (LAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coherus BioSciences Inc (CHRS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Bone Solutions Inc：医療機器：M&Aディール及び事業提携情報
    Summary Bone Solutions Inc (BSI) is a medical device company that provides orthobiologics technology solutions. The company also develops magnesium oxide based technologies for multitude of orthopedic applications. It provides osteocrete bone graft substitute that offers adhere ligaments and tendons …
  • Goldin Properties Holdings Ltd：企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Meiji Holdings Co, Ltd.：企業の戦略・SWOT・財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Banco Pan S.A. (BPAN4)：企業の財務・戦略的SWOT分析
    Banco Pan S.A. (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CITIC Pacific Limited：企業のM&A・事業提携・投資動向
    CITIC Pacific Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CITIC Pacific Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆